跳至主要内容
临床试验/NCT02248129
NCT02248129已完成不适用

Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated in General Practice With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide, the Level of Blood Pressure Control and the Modalities of Arterial Hypertension Management

Boehringer Ingelheim0 个研究点目标入组 4,255 人开始时间: 2006年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
4,255
主要终点
Percentage of patients with low blood pressure

研究概览

简要总结

Study to compare the level of blood pressure control in hypertensive, hypertensive diabetics and hypertensive with renal insufficiency (observed data) in the study population, with the objectives of the High Authority for Health recommendations (benchmark)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Hypertensive patients already treated for at least 1 month with Telmisartan plus hydrochlorothiazide, consulting the physician consecutively for whatever reason

排除标准

  • 未提供

研究组 & 干预措施

Hypertensive patients

干预措施: Telmisartan and hydrochlorothiazide (Drug)

结局指标

主要结局

Percentage of patients with low blood pressure

时间窗: up to 4 weeks

lower than 140/90 mmHg in the general population of hypertensive patients, hypertensive diabetics and hypertensive with renal insufficiency

次要结局

  • Number of patients with adverse events(up to 4 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Pharmaco-epidemiological Study Describing a... | 临床试验